Abstract | OBJECTIVE: METHODS: RESULTS: The overall 5-year survival rate was 50.2%. For 16 cases with staged I-II staged, there were 8 cases with radiotherapy alone, 5 years survival was 50.0%, 6 cases with surgery combined with postoperative radiotherapy, 5 years survival was 83.3%. The difference between the two treatments was not significant in statistics (P = 0.318). For III-IV staged 45 cases, there were 19 cases with simple radiotherapy, 5 years survival was 51.5%, 21 cases with radiotherapy combined with chemotherapy, 5 years survival was 36.4%, 5 cases with surgery combined with postoperative radiotherapy, 5 years survival was 75.0%. The difference among the three treatments was not significant in statistics (P = 0.239). According to T stages, the 5-year survival rates of stage T1-T4 cases were 91.8%, 46.8%, 29.1%, 0% respectively (chi(2) = 30.168, P < 0.001). Multivariate analysis demonstrated that T stage, therapeutic effect of primary site and cervical metastatic lymph node were the independent prognostic factors (P < 0.05). CONCLUSIONS: T stage, the therapeutic effect of primary site and cervical metastatic lymph node were the independent prognostic factors. For I-II staged tonsillar tumor cases, based on organ preservation, were tendency to choice simple radiotherapy. For III-IV staged cases, yet the relationships between therapeutic mode and therapeutic effect still need further researches.
|
Authors | Xin Wang, Fang-Yun Xie, Fei Han, Wei-Han Hu, Ji-Shi Li, Hui-Min Xu |
Journal | Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
(Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi)
Vol. 44
Issue 10
Pg. 848-52
(Oct 2009)
ISSN: 1673-0860 [Print] China |
PMID | 20079056
(Publication Type: English Abstract, Journal Article)
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Squamous Cell
(diagnosis, pathology, therapy)
- Combined Modality Therapy
- Female
- Humans
- Lymphatic Metastasis
- Male
- Middle Aged
- Neoplasm Staging
- Prognosis
- Retrospective Studies
- Survival Rate
- Tonsillar Neoplasms
(diagnosis, pathology, therapy)
|